SCHEMBL7704328

SCHEMBL7704328

CC(=O)NC1=C[CH]CC=C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.33
HSD17B10 Q99714 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
GAA P10253 2/20 0.33
PKM P14618 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
NAPRT Q6XQN6 1/20 0.33
ALDH1A1 P00352 4/20 0.32
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
MAPT P10636 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
CA12 O43570 1/20 0.32
BRD4 O60885 1/20 0.32
NR1I2 O75469 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
MB P02144 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7390229 0.85 GAA (0.31) GAA
SCHEMBL19982850 0.84 SMN1; SMN2 (0.33) LMNASMN1; SMN2HSD17B10L3MBTL1GAA
SCHEMBL11795207 0.74 MEN1 (0.43) PKMMEN1KMT2ATDP1RAB9A
SCHEMBL19983058 0.73 TDP1 (0.34) LMNASMN1; SMN2HSD17B10L3MBTL1GAA
SCHEMBL20429846 0.73 EPHX2 (0.33) LMNASMN1; SMN2HSD17B10L3MBTL1GAA
SCHEMBL19669627 0.72 SMN1; SMN2 (0.37) LMNASMN1; SMN2HSD17B10L3MBTL1GAA
SCHEMBL8115837 0.71 SMN1; SMN2 (0.35) LMNASMN1; SMN2HSD17B10L3MBTL1GAA
SCHEMBL5960697 0.69 SMN1; SMN2 (0.34) LMNASMN1; SMN2HSD17B10L3MBTL1GAA
SCHEMBL3113073 0.68
SCHEMBL22312264 0.68 TDP1 (0.33) LMNASMN1; SMN2HSD17B10L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6352839-B1 PREPARING VIRGINIAMYCINS FROM AN ENGINEERED MICROORGANISMS, HAVING THE ABILITY TO PREVENT BIOSYNTHESIS OF THE PRECURSOR ANTIBIOTIC; THE MICROORGANISM IS CULTURED IN THE PRESENCE OF A SECOND PRECURSOR AND THE STREPTOGRAMIN ANALOG IS RECOVERED AVENTIS PHARMA S.A. (FR) 2002-03-05 US disclosed
EP-0460168-A1 DIRECT POSITIVE EMULSIONS. EASTMAN KODAK CO (US) 1991-12-11 EP disclosed